| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1018876A1 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses |
| 07/19/2000 | EP0769001B1 2-aryl cyclopentane-1,3-dione derivatives |
| 07/19/2000 | EP0514452B2 Use of insulin sensitizing agents to treat hypertension |
| 07/19/2000 | CN1260782A Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
| 07/19/2000 | CN1260779A Epsilon-caprolactam composition and by products |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090942 Process and intermediates for a β3 -adrenergic receptor agonist |
| 07/18/2000 | US6090846 Administering s-ethyl-n-((4-trifluoromethyl)phenyl)isothiourea |
| 07/18/2000 | US6090823 Administering n,n'-propylenedinicotinamide |
| 07/18/2000 | US6090817 Respiratory system disorders; phosphodiesterse inhibitor |
| 07/18/2000 | US6090813 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 07/18/2000 | US6090810 Side effect reduction |
| 07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 07/18/2000 | US6090807 Use of heterocyclic compounds |
| 07/13/2000 | WO2000040571A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 07/13/2000 | WO2000040559A1 Compositions for the treatment of skin diseases |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | WO2000040557A1 Process for the formation of intermediates useful for the preparation of pharmaceuticals |
| 07/13/2000 | WO2000040556A1 Improved pyridine/picoline production process |
| 07/13/2000 | WO2000040552A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040237A1 Antiviral method using mek inhibitors |
| 07/13/2000 | WO2000040210A2 Topical compositions comprising protected functional thiols |
| 07/13/2000 | WO2000023063A3 Methods for inhibiting diabetic complications |
| 07/13/2000 | DE19845405C2 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
| 07/13/2000 | CA2358578A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | CA2358438A1 Antiviral method using mek inhibitors |
| 07/13/2000 | CA2356966A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP1017658A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
| 07/12/2000 | EP1017650A1 Asymmetric hydrogenation |
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases |
| 07/12/2000 | CN1259947A 2-aryl-naphthyridin-4-ones as antitumor agent |
| 07/12/2000 | CN1259936A Method for producing nitroguanidine derivatives |
| 07/12/2000 | CN1259932A Halogenated acrylates and polymers derived therefrom |
| 07/12/2000 | CN1259346A Optically pure compound as medicinal use |
| 07/11/2000 | US6087524 Preparation of vanadium antimonate based catalysts using Sno2 ·xH2 o |
| 07/11/2000 | US6087507 Separation of pyridine or pyridine derivatives from aqueous solutions |
| 07/11/2000 | US6087506 Amides or esters of pyridine |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087504 Coupling 1-alkylpyridinium salt with base in alkaline metal cyanide, filtration, quenching and oxidation |
| 07/11/2000 | US6087383 A viricide have high solubility/dissolution rate and oral bioavailability |
| 07/11/2000 | US6087379 Cyclic amine derivatives |
| 07/11/2000 | US6087367 Potent inducers of terminal differentiation and methods of use thereof |
| 07/11/2000 | US6087365 Treating drug-resistant malaria in a mammal |
| 07/11/2000 | US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 07/06/2000 | WO2000039118A1 Aromatic amides |
| 07/06/2000 | WO2000039117A1 HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
| 07/06/2000 | WO2000039108A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000039095A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | WO2000039094A1 Substituted pyridine herbicides |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000039062A1 Liquid crystalline trifluoro-substituted compounds |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038716A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000021910A3 1,2-disubstituted cyclopropanes |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2362492A1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | CA2361149A1 Aromatic amides |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358095A1 Heteroroaromatic amides as inhibitor of factor xa |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356547A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356319A1 Thyroid receptor ligands |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2349557A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2348740A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2320730A1 Thrombin or factor xa inhibitors |
| 07/05/2000 | EP1016661A1 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals |
| 07/05/2000 | EP1016654A2 Process for the preparation of substituted aromatic and heteroaromatic aldehydes and carboxylic acids |
| 07/05/2000 | EP1015501A1 Polymerisation catalysts |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015413A1 Anti-cancer compounds |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 07/05/2000 | EP1014962A1 Antithrombotic agents |
| 07/05/2000 | EP0882138B1 Stereoselective preparation of 2-substituted succinic derivatives |
| 07/05/2000 | EP0882019B1 Pyridine derivatives as fungicides |